Key result
Heart transplantation successfully treats multiple recurrent cardiac myxomas, achieving tumor clearance and NYHA class I status.
Why the study?
Is orthotopic heart transplantation an effective treatment for multiple recurrent cardiac myxoma?
Case Report (n=1)
Is orthotopic heart transplantation an effective treatment for multiple recurrent cardiac myxoma?
Orthotopic heart transplantation can be a viable treatment option for patients with multiple recurrent cardiac myxomas.
May warrant evaluation for transplantation in refractory recurrent cardiac myxoma; leaves open long-term efficacy and selection criteria.
Primary cardiac myxoma is the most common primary cardiac tumor. Tumor resection is the treatment of choice and overall long-term prognosis is good and recurrence is rare. This report presents a case of a young girl who presented with multiple recurrent cardiac myxoma. She underwent 3 sternotomy surgeries of 3 separated episodes of cardiac myxoma resection. On the fourth recurrence, the patient underwent orthotopic heart transplant. The patient tolerated the procedure well and is alive 6 months after the procedure with NYHA class I. We reviewed evidences and summarized reported cases of orthotopic heart transplant operation for primary cardiac tumor in the literature.
No takes yet. Share an insight, caveat, or question.
Kewcharoen et al. (2018) conducted a case report in Recurrent Cardiac Myxoma (n=1). Orthotopic heart transplantation was evaluated on Clinical outcome, survival, and tumor recurrence. Orthotopic heart transplantation successfully treated a 17-year-old girl with multiple recurrent cardiac myxomas, leaving her tumor-free and in NYHA class I status at 6-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: